Shaunak Deepak

Stock Analyst at HC Wainwright & Co.

(2.34)
# 2,561
Out of 4,900 analysts
1
Total ratings
50%
Success rate
16.77%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Shaunak Deepak

CytomX Therapeutics
Mar 27, 2017
Initiates: Buy
Price Target: $24
Current: $2.39
Upside: +904.18%